2018. Cella D et al. – Quality of life outcomes for cabozantinib versus everolimus in patients with metastatic renal cell carcinoma: METEOR phase III randomized trial
2017. Medic G et al. – A systematic literature review of cysteamine bitartrate in the treatment of nephropathic cystinosis
Posters & Presentations
2017. ISPOR European Congress – Symptom deterioration in patients with metastatic renal cell carcinoma treated with cabozantinib or everolimus
2017. ISOQOL Annual Conference – Long-term trends in health-related quality of life in patients with metastatic renal cell carcinoma treated with carbozantinib or everolimus
2016. ISPOR European Congress – Survival and Resource Use in the Treatment of Metastatic Renal Cell Carcinoma in Sweden – A Retrospective Analysis of Data from National Registries
2014. ISPOR European Congress – Accept® Questionnaire: Relation between Acceptance and Compliance in Liver- and Kidney-Transplanted Patients Converted to Once-Daily Tacrolimus
2013. ISPOR Annual European Congress – The Cost Implications of Renal Denervation Therapy at the Hospital Level in the UK
